Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Gain	Accumulated Deficit
Beginning balance at Dec. 31, 2023	$ 235,193	$ 62	$ 744,940	$ (136)	$ (509,673)
Beginning balance, Shares at Dec. 31, 2023		61,915,367
Issuance of common stock under employee benefit plans	1,651		1,651
Issuance of common stock under employee benefit plans, Shares		214,094
Vesting of restricted stock awards, Shares		11,550
Stock-based compensation expense	3,916		3,916
Unrealized gain (loss) on marketable securities	(298)			(298)
Net Income (Loss)	(26,870)				(26,870)
Ending balance at Mar. 31, 2024	213,592	$ 62	750,507	(434)	(536,543)
Ending balance, Shares at Mar. 31, 2024		62,141,011
Beginning balance at Dec. 31, 2023	235,193	$ 62	744,940	(136)	(509,673)
Beginning balance, Shares at Dec. 31, 2023		61,915,367
Unrealized gain (loss) on marketable securities	(230)
Net Income (Loss)	28,539
Ending balance at Jun. 30, 2024	273,790	$ 62	755,228	(366)	(481,134)
Ending balance, Shares at Jun. 30, 2024		62,250,631
Beginning balance at Dec. 31, 2023	235,193	$ 62	744,940	(136)	(509,673)
Beginning balance, Shares at Dec. 31, 2023		61,915,367
Ending balance at Dec. 31, 2024	243,034	$ 54	762,248	130	(519,398)
Ending balance, Shares at Dec. 31, 2024		53,968,303
Beginning balance at Mar. 31, 2024	213,592	$ 62	750,507	(434)	(536,543)
Beginning balance, Shares at Mar. 31, 2024		62,141,011
Issuance of common stock under employee benefit plans	377		377
Issuance of common stock under employee benefit plans, Shares		98,844
Vesting of restricted stock awards, Shares		10,776
Stock-based compensation expense	4,344		4,344
Unrealized gain (loss) on marketable securities	68			68
Net Income (Loss)	55,409				55,409
Ending balance at Jun. 30, 2024	273,790	$ 62	755,228	(366)	(481,134)
Ending balance, Shares at Jun. 30, 2024		62,250,631
Beginning balance at Dec. 31, 2024	243,034	$ 54	762,248	130	(519,398)
Beginning balance, Shares at Dec. 31, 2024		53,968,303
Vesting of restricted stock awards, Shares		11,003
Stock-based compensation expense	3,167		3,167
Unrealized gain (loss) on marketable securities	(60)			(60)
Net Income (Loss)	(17,655)				(17,655)
Ending balance at Mar. 31, 2025	228,486	$ 54	765,415	70	(537,053)
Ending balance, Shares at Mar. 31, 2025		53,979,306
Beginning balance at Dec. 31, 2024	243,034	$ 54	762,248	130	(519,398)
Beginning balance, Shares at Dec. 31, 2024		53,968,303
Unrealized gain (loss) on marketable securities	(48)
Net Income (Loss)	(34,951)
Ending balance at Jun. 30, 2025	214,378	$ 54	768,591	82	(554,349)
Ending balance, Shares at Jun. 30, 2025		54,091,588
Beginning balance at Mar. 31, 2025	228,486	$ 54	765,415	70	(537,053)
Beginning balance, Shares at Mar. 31, 2025		53,979,306
Issuance of common stock under employee benefit plans	301		301
Issuance of common stock under employee benefit plans, Shares		103,780
Vesting of restricted stock awards, Shares		8,502
Stock-based compensation expense	2,875		2,875
Unrealized gain (loss) on marketable securities	12			12
Net Income (Loss)	(17,296)				(17,296)
Ending balance at Jun. 30, 2025	$ 214,378	$ 54	$ 768,591	$ 82	$ (554,349)
Ending balance, Shares at Jun. 30, 2025		54,091,588